Prof. PeptideProf. Peptide

Everything you need for peptide research, in one place

72

Peptide profiles

75

Compounds compared

169

Verified discount codes

100%

Independent research

Certificates lab-checked in the last 7 days, as of November 6, 2026: Formal Peptides, Exactide, 20 Aminos and 12 more.

Prof. Peptide provides peptide research for educational purposes only. Nothing on this site constitutes medical advice or endorses human use of research peptides.

Everything a researcher needs

From peptide mechanisms to reconstitution math — Prof. Peptide covers it all, clearly and credibly.

Latest News

View all news

November 6, 2026

Retatrutide for Sleep Apnea: Two Phase 3 Trials in the NEJM Report Lower Apnea-Hypopnea Index Scores

The New England Journal of Medicine published TRIUMPH-1-OSA (243 adults without type 2 diabetes) and TRIUMPH-2-OSA (448 with it) on October 21, 2026. At 80 weeks the apnea-hypopnea index changed by up to -34.3 and -25.4 events per hour with retatrutide versus about -10 with placebo. The results on both estimands, and how they sit beside tirzepatide's approved sleep apnea indication; no trial has compared the two.

Read more →

November 6, 2026

Orthopaedic Journal JAAOS Reviews BPC-157, Thymosin Beta-4 and TB-500: No Controlled Orthopaedic Evidence

A narrative review in the Journal of the American Academy of Orthopaedic Surgeons (October 27, 2026) found one small uncontrolled human case series for BPC-157 in musculoskeletal use, no controlled orthopaedic evidence for any of the three compounds, and no validated equivalence between TB-500 and full-length thymosin beta-4. It concludes that routine clinical use cannot currently be recommended.

Read more →

October 31, 2026

HHS Will Not Act Against 503A Pharmacies Compounding Six Peptides: What the Policy Requires

HHS published a draft, interim policy on October 30, 2026 (91 FR 68526): it does not intend to take enforcement action against State-licensed pharmacies, Federal facilities or licensed physicians compounding BPC-157, Epitalon, KPV, MOTS-c, Semax or TB-500 under ten conditions, from registered manufacturers, against a patient-specific prescription, in set dosage forms only. It is not FDA approval, does not list the six on the 503A Bulks List and does nothing for research-use-only sellers. Comments are open for two weeks.

Read more →
Why Prof. Peptide

Built for researchers

Most peptide sites exist to sell products. Prof. Peptide exists to educate. We're independent, ad-light, and committed to presenting research accurately — including limitations and unknowns.

  • ✓Content is editorially independent and research-driven
  • ✓Every peptide profile cites primary research literature
  • ✓Calculator math is transparent and peer-reviewable
  • ✓Discount codes are manually verified before publishing

Now on iOS

The all-in-one peptide tracker

Log doses, see estimated levels, calculate reconstitution, and search 70+ peptides by name or brand — all in one private iOS app.

Get the App

Don't overpay for peptides.

Prof. Peptide finds the best deals and delivers them to your inbox.